AACC 2019 Booth Presentation: Defining the Downstream Impact of Laboratory Stewardship

Thirteen billion laboratory tests are performed annually in the U.S., meaning lab data influences 70–80% of medical decisions. How do we take that data and use it to improve care on a system-wide basis? From troponin case management to pharmacy collaboration, Dr. Fletcher will cover how laboratory stewardship initiatives can impact downstream costs and why they are integral to enhanced patient care.

Originally presented on August 6, 2019 in Anaheim, California.

Lecture Presenter

Andrew Fletcher, MD, CPE

Andrew Fletcher, MD, CPE

Medical Director, Consultative Services
ARUP Laboratories

Dr. Fletcher is a board-certified anatomic/clinical pathologist and certified physician executive with significant experience in leading quality across an organization and reducing clinical variation to effectively drive safety and value. Most recently, he was instrumental in developing a utilization management program that captured over $1 million in cost savings within the first year and significantly improved downstream metrics driving utilization in various areas, including pharmacy, radiology, length of stay, and sepsis mortality. Dr. Fletcher has a doctor of medicine degree from the Mercer University School of Medicine in Georgia and is currently pursuing his MBA from the University of Massachusetts at Amherst. He completed a surgery internship at the Geisinger Medical System in Pennsylvania, as well as a residency in anatomic and clinical pathology and a cytopathology fellowship at the University of Florida in Gainesville. Dr. Fletcher has received numerous awards for quality and utilization, including research grants for blood utilization.

Sponsored by:

University of Utah School of Medicine, Department of Pathology, and ARUP Laboratories